Literature DB >> 18654799

Exploration of the utility of ancestry informative markers for genetic association studies of African Americans with type 2 diabetes and end stage renal disease.

Keith L Keene1, Josyf C Mychaleckyj, Tennille S Leak, Shelly G Smith, Peter S Perlegas, Jasmin Divers, Carl D Langefeld, Barry I Freedman, Donald W Bowden, Michèle M Sale.   

Abstract

Admixture and population stratification are major concerns in genetic association studies. We wished to evaluate the impact of admixture using empirically derived data from genetic association studies of African Americans (AA) with type 2 diabetes (T2DM) and end-stage renal disease (ESRD). Seventy ancestry informative markers (AIMs) were genotyped in 577 AA with T2DM-ESRD, 596 AA controls, 44 Yoruba Nigerian (YRI) and 39 European American (EA) controls. Genotypic data and association results for eight T2DM candidate gene studies in our AA population were included. Ancestral estimates were calculated using FRAPPE, ADMIXMAP and STRUCTURE for all AA samples, using varying numbers of AIMs (25, 50, and 70). Ancestry estimates varied significantly across all three programs with the highest estimates obtained using STRUCTURE, followed by ADMIXMAP; while FRAPPE estimates were the lowest. FRAPPE estimates were similar using varying numbers of AIMs, while STRUCTURE estimates using 25 AIMs differed from estimates using 50 and 70 AIMs. Female T2DM-ESRD cases showed higher mean African proportions as compared to female controls, male cases, and male controls. Age showed a weak but significant correlation with individual ancestral estimates in AA cases (r2 = 0.101; P = 0.019) and in the combined set (r2 = 0.131; P = 3.57 x 10(-5)). The absolute difference between frequencies in parental populations, absolute delta, was correlated with admixture impact for dominant, additive, and recessive genotypic models of association. This study presents exploratory analyses of the impact of admixture on studies of AA with T2DM-ESRD and supports the use of ancestral proportions as a means of reducing confounding effects due to admixture.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18654799      PMCID: PMC2786006          DOI: 10.1007/s00439-008-0532-6

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  34 in total

1.  Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? 1962.

Authors:  J V Neel
Journal:  Bull World Health Organ       Date:  1999       Impact factor: 9.408

2.  Information on ancestry from genetic markers.

Authors:  Carrie Lynn Pfaff; Jill Barnholtz-Sloan; Jennifer K Wagner; Jeffrey C Long
Journal:  Genet Epidemiol       Date:  2004-05       Impact factor: 2.135

3.  The genetic structure of admixed populations.

Authors:  J C Long
Journal:  Genetics       Date:  1991-02       Impact factor: 4.562

4.  Population structure, admixture, and aging-related phenotypes in African American adults: the Cardiovascular Health Study.

Authors:  Alexander P Reiner; Elad Ziv; Denise L Lind; Caroline M Nievergelt; Nicholas J Schork; Steven R Cummings; Angie Phong; Esteban González Burchard; Tamara B Harris; Bruce M Psaty; Pui-Yan Kwok
Journal:  Am J Hum Genet       Date:  2005-01-19       Impact factor: 11.025

5.  Diabetes mellitus: discrimination between single locus and multifactorial models of inheritance.

Authors:  M J Goodman; C S Chung
Journal:  Clin Genet       Date:  1975-07       Impact factor: 4.438

Review 6.  Twin studies in diabetes mellitus.

Authors:  C H Hawkes
Journal:  Diabet Med       Date:  1997-05       Impact factor: 4.359

7.  Genetic linkage analysis of growth factor loci and end-stage renal disease in African Americans.

Authors:  B I Freedman; H Yu; B J Spray; S S Rich; C B Rothschild; D W Bowden
Journal:  Kidney Int       Date:  1997-03       Impact factor: 10.612

8.  Linkage analysis between loci in the renin-angiotensin axis and end-stage renal disease in African Americans.

Authors:  H Yu; D W Bowden; B J Spray; S S Rich; B I Freedman
Journal:  J Am Soc Nephrol       Date:  1996-12       Impact factor: 10.121

9.  Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial.

Authors:  K L Margolis; D E Bonds; R J Rodabough; L Tinker; L S Phillips; C Allen; T Bassford; G Burke; J Torrens; B V Howard
Journal:  Diabetologia       Date:  2004-07-14       Impact factor: 10.122

10.  Familial aggregation of cardiovascular diseases in African-American pedigrees.

Authors:  C Rotimi; R Cooper; G Cao; C Sundarum; D McGee
Journal:  Genet Epidemiol       Date:  1994       Impact factor: 2.135

View more
  22 in total

1.  Candidate genes for non-diabetic ESRD in African Americans: a genome-wide association study using pooled DNA.

Authors:  Meredith A Bostrom; Lingyi Lu; Jeff Chou; Pamela J Hicks; Jianzhao Xu; Carl D Langefeld; Donald W Bowden; Barry I Freedman
Journal:  Hum Genet       Date:  2010-06-08       Impact factor: 4.132

2.  Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans.

Authors:  Barry I Freedman; Carl D Langefeld; Mariana Murea; Lijun Ma; James D Otvos; Jolyn Turner; Peter A Antinozzi; Jasmin Divers; Pamela J Hicks; Donald W Bowden; Michael V Rocco; John S Parks
Journal:  Nephrol Dial Transplant       Date:  2011-09-19       Impact factor: 5.992

3.  Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy.

Authors:  Meredith A Bostrom; W H Linda Kao; Man Li; Hanna E Abboud; Sharon G Adler; Sudha K Iyengar; Paul L Kimmel; Robert L Hanson; Susanne B Nicholas; Rebekah S Rasooly; John R Sedor; Josef Coresh; Orly F Kohn; David J Leehey; Denyse Thornley-Brown; Erwin P Bottinger; Michael S Lipkowitz; Lucy A Meoni; Michael J Klag; Lingyi Lu; Pamela J Hicks; Carl D Langefeld; Rulan S Parekh; Donald W Bowden; Barry I Freedman
Journal:  Am J Kidney Dis       Date:  2011-11-25       Impact factor: 8.860

4.  Implication of European-derived adiposity loci in African Americans.

Authors:  J M Hester; M R Wing; J Li; N D Palmer; J Xu; P J Hicks; B H Roh; J M Norris; L E Wagenknecht; C D Langefeld; B I Freedman; D W Bowden; M C Y Ng
Journal:  Int J Obes (Lond)       Date:  2011-07-12       Impact factor: 5.095

5.  The ras responsive transcription factor RREB1 is a novel candidate gene for type 2 diabetes associated end-stage kidney disease.

Authors:  Jason A Bonomo; Meijian Guan; Maggie C Y Ng; Nicholette D Palmer; Pamela J Hicks; Jacob M Keaton; Janice P Lea; Carl D Langefeld; Barry I Freedman; Donald W Bowden
Journal:  Hum Mol Genet       Date:  2014-07-15       Impact factor: 6.150

6.  Analysis of coding variants identified from exome sequencing resources for association with diabetic and non-diabetic nephropathy in African Americans.

Authors:  Jessica N Cooke Bailey; Nicholette D Palmer; Maggie C Y Ng; Jason A Bonomo; Pamela J Hicks; Jessica M Hester; Carl D Langefeld; Barry I Freedman; Donald W Bowden
Journal:  Hum Genet       Date:  2014-01-03       Impact factor: 4.132

7.  Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans.

Authors:  Jessica N Cooke; Meredith A Bostrom; Pamela J Hicks; Maggie C Y Ng; Jacklyn N Hellwege; Mary E Comeau; Jasmin Divers; Carl D Langefeld; Barry I Freedman; Donald W Bowden
Journal:  Nephrol Dial Transplant       Date:  2011-10-03       Impact factor: 5.992

8.  Association of polymorphisms in the klotho gene with severity of non-diabetic ESRD in African Americans.

Authors:  Meredith A Bostrom; Pamela J Hicks; Lingyi Lu; Carl D Langefeld; Barry I Freedman; Donald W Bowden
Journal:  Nephrol Dial Transplant       Date:  2010-04-22       Impact factor: 5.992

9.  Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans.

Authors:  Pamela J Hicks; Carl D Langefeld; Lingyi Lu; Anthony J Bleyer; Jasmin Divers; Patrick H Nachman; Vimal K Derebail; Donald W Bowden; Barry I Freedman
Journal:  Kidney Int       Date:  2011-08-17       Impact factor: 10.612

10.  Relevance of the ACTN4 gene in African-Americans with non-diabetic end-stage renal disease.

Authors:  Meredith A Bostrom; Peter Perlegas; Lingyi Lu; Pamela J Hicks; Greg Hawkins; Maggie C Y Ng; Carl D Langefeld; Barry I Freedman; Donald W Bowden
Journal:  Am J Nephrol       Date:  2012-09-04       Impact factor: 3.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.